- 21st Century Cures Bill Advances in House
- June 2, 2015
- Law Firm: McDonald Hopkins LLC - Cleveland Office
- This week, the House Energy and Commerce Committee passed the 21st Century Cures Act out of committee by a unanimous 51-0 vote.
“This historic day marks a big bipartisan step forward on our path to cures. We have all said too many early good-byes to people we love and treasure. Every single person has a common goal: we want more time with those we love. In this, the greatest country in the world, Americans deserve a system second to none. We can and must do better. The time for 21st Century Cures is now.” Said Energy and Commerce Chairman Rep. Fred Upton (R-Mich.) in a press release issued after the move.
Challenges for the legislation, however, remain - namely over the question of how to pay for it and the dramatically slower pace at which the Senate plans on working on the issue.
The current House draft of the bill allocates $2 billion a year for five years to the National Institutes of Health. It also aims to support researchers and young scientists, streamline clinical trials, and establish a public-private partnership to accelerate the discovery, development, and delivery of cures, treatments, and preventive measures. Additionally, it would require the FDA to issue guidance in the development of biomarkers, precision drugs, and biological products.